Blueshift Ideas Discusses MAKO Surgical

Blueshift Ideas is out with a series of tweets on MAKO Surgical Corp. (NASDAQ: MAKO) and the joint replacement industry.

Blueshift noted that MAKO Surgical needs clinical results, and a hip application in order to gain more market share. There are anywhere between four hundred and six hundred thousand knee replacements in the U.S. every year, and there is an equal number of hip replacements as well. A partial knee replacement comprises 10-25% of the market place.

The San Francisco-based research firm said that surgeons and orthopedic pros are having a tough time adopting the MAKO Rio robotic system due to high cost and the lack of studies showing a favorable outcome. MAKO's plasty partial-knee replacement procedure takes longer to perform than a traditional surgery and is not easy for surgeons to learn. The total hip replacement is considered a more mainstream procedure than partial knee replacement, which could "drive wider adoption of MAKO system."